Implementing thrombosis guidelines in cancer patients: a review

Dominique Farge-Bancel1, Henri Bounameaux2, Benjamin Brenner3

  • 1Assistance Publique-Hôpitaux de Paris, Internal Medicine and Vascular Disease Unit, Saint-Louis Hospital; Sorbonne Paris Cité, Paris 7 Diderot University, Paris, France;

Summary

Venous thromboembolism (VTE) is a major cause of death in cancer patients, often underestimated by physicians. An individualized approach to VTE prophylaxis is recommended for all cancer patients.

Related Concept Videos